Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Pfizer vaccine data wins backing of U.S. FDA

Stock MarketsDec 08, 2020 02:30PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Pfizer (NYSE:PFE) cleared the next hurdle in the race to get its COVID-19 vaccine approved for emergency use in the U.S. after the Food and Drug Administration on Tuesday released documents that did not raise any new issues about its safety or efficacy.

The analysis, conducted by FDA staff, affirmed that the coronavirus vaccine, developed by Pfizer and its German partner BioNTech, was 95% effective in preventing COVID-19 after two doses.

The results also show some protection begins even after the first dose. Though the agency's staff noted that more data would be needed to assess the potential of a single shot.

The Food and Drug Administration posted its analysis online ahead of a meeting on Thursday in which outside experts plan to discuss the documents and whether Pfizer's shot should be authorized for emergency use.

This comes as Britain on Tuesday began a vaccination drive using the Pfizer-Biontech vaccine, making Britons the world's first recipients outside of clinical trials.

Meanwhile back in the U.S., concerns are growing about vaccine supplies and timelines for inoculating Americans after the New York Times reported that the Trump administration had the opportunity over the summer to buy more doses of Pfizer's vaccine but declined.

Meaning, according to the report, that Pfizer might not be able deliver more than the initial deal promised until June of next year.

The Trump administration is pushing back on the report, saying the U.S. made other supply deals with other companies, when those vaccines get approved.

One administration official told Reuters the White House is still confident the U.S. will be able to accommodate any American who wants to be vaccinated by the middle of next year.

Pfizer vaccine data wins backing of U.S. FDA
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email